We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Judge Denies Compounder’s Motion to Dismiss Allergan’s False Advertising Complaint
Judge Denies Compounder’s Motion to Dismiss Allergan’s False Advertising Complaint
A federal judge refused to dismiss a false advertising lawsuit filed by Allergan against drug compounder Imprimis Pharmaceuticals concerning its dry-eye drug Klarity, meant to compete with Allergan’s Restasis.